Literature DB >> 29049843

Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.

Grant M Fischer1,2,3, Y N Vashisht Gopal2,3, Jennifer L McQuade2, Weiyi Peng2, Ralph J DeBerardinis4,5, Michael A Davies2,3,6.   

Abstract

Melanomas are metabolically heterogeneous, and they are able to adapt in order to utilize a variety of fuels that facilitate tumor progression and metastasis. The significance of metabolism in melanoma is supported by growing evidence of impact on the efficacy of contemporary therapies for this disease. There are also data to support that the metabolic phenotypes of melanoma cells depend upon contributions from both intrinsic oncogenic pathways and extrinsic factors in the tumor microenvironment. This review summarizes current understanding of the metabolic processes that promote cutaneous melanoma tumorigenesis and progression, the regulation of cancer cell metabolism by the tumor microenvironment, and the impact of metabolic pathways on targeted and immune therapies.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  glycolysis; melanoma; metabolism; oxidative phosphorylation; tumor microenvironment

Mesh:

Year:  2017        PMID: 29049843      PMCID: PMC5742019          DOI: 10.1111/pcmr.12661

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  170 in total

1.  Microarray analysis of differentially expressed genes regulating lipid metabolism during melanoma progression.

Authors:  Venil N Sumantran; Pratik Mishra; N Sudhakar
Journal:  Indian J Biochem Biophys       Date:  2015-04       Impact factor: 1.918

2.  Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange.

Authors:  Christian Stock; Birgit Gassner; Christof R Hauck; Hannelore Arnold; Sabine Mally; Johannes A Eble; Peter Dieterich; Albrecht Schwab
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

3.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

4.  Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.

Authors:  Karina G Zecchin; Franco A Rossato; Helena F Raposo; Daniela R Melo; Luciane C Alberici; Helena C F Oliveira; Roger F Castilho; Ricardo D Coletta; Aníbal E Vercesi; Edgard Graner
Journal:  Lab Invest       Date:  2010-08-30       Impact factor: 5.662

Review 5.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

6.  Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.

Authors:  Jonathan R Brody; Christina L Costantino; Adam C Berger; Takami Sato; Michael P Lisanti; Charles J Yeo; Robert V Emmons; Agnieszka K Witkiewicz
Journal:  Cell Cycle       Date:  2009-06-15       Impact factor: 4.534

Review 7.  Carbonic anhydrase IX: regulation and role in cancer.

Authors:  Martin Benej; Silvia Pastorekova; Jaromir Pastorek
Journal:  Subcell Biochem       Date:  2014

8.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

Review 9.  Metabolic rewiring in melanoma.

Authors:  B I Ratnikov; D A Scott; A L Osterman; J W Smith; Z A Ronai
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

10.  A novel AKT3 mutation in melanoma tumours and cell lines.

Authors:  M A Davies; K Stemke-Hale; C Tellez; T L Calderone; W Deng; V G Prieto; A J F Lazar; J E Gershenwald; G B Mills
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more
  59 in total

1.  A Fluorescence-Based Assay for Measuring Glucose Uptake in Living Melanoma Cells.

Authors:  Jelena Grahovac; Marijana Pavlović; Marija Ostojić
Journal:  Methods Mol Biol       Date:  2021

2.  Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.

Authors:  Karthik Balakrishnan; Kumaresan Ganesan
Journal:  Funct Integr Genomics       Date:  2020-09-19       Impact factor: 3.410

3.  Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.

Authors:  Yan Qu; Shuqing Zhang; Yan Zhang; Xien Feng; Fengjuan Wang
Journal:  Virchows Arch       Date:  2020-11-12       Impact factor: 4.064

4.  Oxidative Phosphorylation Promotes Primary Melanoma Invasion.

Authors:  Amel Salhi; Alexander C Jordan; Irineu I Bochaca; Allison Izsak; Farbod Darvishian; Yariv Houvras; Keith M Giles; Iman Osman
Journal:  Am J Pathol       Date:  2020-03-03       Impact factor: 4.307

5.  TLR4 knockout can improve dysfunction of β-cell by rebalancing proteomics disorders in pancreas of obese rats.

Authors:  Sunjie Yan; Zhen Jiang; Ling Cheng; Youfen Lin; Beibei Fan; Liufen Luo; Yuanli Yan; Liyong Yang; Ximei Shen
Journal:  Endocrine       Date:  2019-10-09       Impact factor: 3.633

Review 6.  Biophysical characterization of melanoma cell phenotype markers during metastatic progression.

Authors:  Anna Sobiepanek; Alessio Paone; Francesca Cutruzzolà; Tomasz Kobiela
Journal:  Eur Biophys J       Date:  2021-03-17       Impact factor: 1.733

7.  Effect of hypoxia factors gene silencing on ROS production and metabolic status of A375 malignant melanoma cells.

Authors:  Ivana Špaková; Miroslava Rabajdová; Helena Mičková; Wolfgang F Graier; Mária Mareková
Journal:  Sci Rep       Date:  2021-05-14       Impact factor: 4.996

Review 8.  Rethinking the biology of metastatic melanoma: a holistic approach.

Authors:  Hendrik Hld Vandyck; Lisa M Hillen; Francesca M Bosisio; Joost van den Oord; Axel Zur Hausen; Véronique Winnepenninckx
Journal:  Cancer Metastasis Rev       Date:  2021-04-19       Impact factor: 9.264

9.  Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma.

Authors:  Xiaowei Qiu; Yehong Tian; Jingnan Xu; Xin Jiang; Zeyu Liu; Xuewei Qi; Xin Chang; Jianxin Zhao; Jinchang Huang
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

10.  A new metabolic signature contributes to disease progression and predicts worse survival in melanoma.

Authors:  Mengdi Wan; Binyu Zhuang; Xiao Dai; Liang Zhang; Fangqing Zhao; Yan You
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.